Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: DENOSUMAB, . Treffer: 29

2020

Kerr, DA; Brcic, I; Diaz-Perez, JA; Shih, A; Wilky, BA; Pretell-Mazzini, J; Subhawong, TK; Nielsen, GP; Rosenberg, AE Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
Am J Surg Pathol. 2020;
PubMed FullText FullText_MUG

 

Roessner, A; Smolle, M; Haybäck, J [Giant cell tumor of bone : Morphology, molecular pathogenesis, and differential diagnosis].
Pathologe. 2020; 41(2):134-142
Web of Science PubMed FullText FullText_MUG

 

2019

Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Bilezikian, JP; Lin, CJF; Brown, JP; Wang, AT; Yin, X; Ebeling, PR; Fahrleitner-Pammer, A; Franek, E; Gilchrist, N; Miller, PD; Simon, JA; Valter, I; Zerbini, CAF; Libanati, C; Chines, A Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.
Osteoporos Int. 2019; 30(9): 1855-1864. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dimai, HP; Ljuhar, R; Ljuhar, D; Norman, B; Nehrer, S; Kurth, A; Fahrleitner-Pammer, A Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial.
Skeletal Radiol. 2019; 48(7):1023-1032 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
LANCET ONCOL. 2019; 20(3): 339-351.
Web of Science PubMed FullText FullText_MUG

 

Scheipl, S; Liegl-Atzwanger, B; Szkandera, J; Rinner, B; Viertler, C; Friesenbichler, J; Bergovec, M; Leithner, A [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Orthopade. 2019; 48(9): 776-783. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wieser, V; Sprung, S; Tsibulak, I; Haybaeck, J; Hackl, H; Fiegl, H; Marth, C; Zeimet, AG Clinical Impact of RANK Signalling in Ovarian Cancer.
Cancers (Basel). 2019; 11(6): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Dempster, DW; Brown, JP; Fahrleitner-Pammer, A; Kendler, D; Rizzo, S; Valter, I; Wagman, RB; Yin, X; Yue, SV; Boivin, G Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
J Clin Endocrinol Metab. 2018; 103(7):2498-2509 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Bone, HG; Wagman, RB; Brandi, ML; Brown, JP; Chapurlat, R; Cummings, SR; Czerwiński, E; Fahrleitner-Pammer, A; Kendler, DL; Lippuner, K; Reginster, JY; Roux, C; Malouf, J; Bradley, MN; Daizadeh, NS; Wang, A; Dakin, P; Pannacciulli, N; Dempster, DW; Papapoulos, S 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.
Lancet Diabetes Endocrinol. 2017; 5(7):513-523
Web of Science PubMed FullText FullText_MUG

 

Fahrleitner-Pammer, A; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Toffis, C; Frieling, I; Geusens, P; Makras, P; Boschitsch, E; Callens, J; Anastasilakis, AD; Niedhart, C; Resch, H; Kalouche-Khalil, L; Hadji, P Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.
Arch Osteoporos. 2017; 12(1):58-58 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rao, S; Sigl, V; Wimmer, RA; Novatchkova, M; Jais, A; Wagner, G; Handschuh, S; Uribesalgo, I; Hagelkruys, A; Kozieradzki, I; Tortola, L; Nitsch, R; Cronin, SJ; Orthofer, M; Branstetter, D; Canon, J; Rossi, J; D'Arcangelo, M; Botling, J; Micke, P; Fleur, L; Edlund, K; Bergqvist, M; Ekman, S; Lendl, T; Popper, H; Takayanagi, H; Kenner, L; Hirsch, FR; Dougall, W; Penninger, JM RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.
Genes Dev. 2017; 31(20):2099-2112 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tsourdi, E; Langdahl, B; Cohen-Solal, M; Aubry-Rozier, B; Eriksen, EF; Guañabens, N; Obermayer-Pietsch, B; Ralston, SH; Eastell, R; Zillikens, MC Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
Bone. 2017; 105(21-22):11-17
Web of Science PubMed FullText FullText_MUG

 

2016

Khan, AA; Morrison, A; Kendler, DL; Rizzoli, R; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Dabagh, RA; Davison, KS; Sándor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J; International Task Force on Osteonecrosis of the Jaw Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
J Clin Densitom. 2016; 20(1):8-24
Web of Science PubMed FullText FullText_MUG

 

Svejda, B; Muschitz, Ch; Gruber, R; Brandtner, Ch; Svejda, Ch; Gasser, RW; Santler, G; Dimai, HP [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Wien Med Wochenschr. 2016; 166(1-2):68-74 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Assaf, AT; Zrnc, TA; Remus, CC; Adam, G; Zustin, J; Heiland, M; Friedrich, RE; Derlin, T Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
J Craniomaxillofac Surg. 2015; 43(8):1461-1469
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Austrian Breast and Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
LANCET. 2015; 386(9992): 433-443.
Web of Science PubMed FullText FullText_MUG

 

Hadji, P; Papaioannou, N; Gielen, E; Feudjo Tepie, M; Zhang, E; Frieling, I; Geusens, P; Makras, P; Resch, H; Möller, G; Kalouche-Khalil, L; Fahrleitner-Pammer, A Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
Osteoporos Int. 2015; 26(10):2479-2489 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Khan, AA; Morrison, A; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Al Dabagh, R; Davison, KS; Kendler, DL; Sándor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J; International Task Force on Osteonecrosis of the Jaw Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
J Bone Miner Res. 2015; 30(1): 3-23. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Jacobsen, C; Zemann, W; Obwegeser, JA; Grätz, KW; Metzler, P The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
Oral Maxillofac Surg. 2014; 18(1):31-37
PubMed FullText FullText_MUG

 

Rordorf, T; Hassan, AA; Azim, H; Alexandru, E; Er, O; Gokmen, E; Güral, Z; Mardiak, J; Minchev, V; Peintinger, F; Szendroi, M; Takac, I; Tesarova, P; Vorobiof, D; Vrbanec, D; Yildiz, R; Yücel, S; Zekri, J; Oyan, B; Central European Cooperative Oncology Group (CECOG); Swiss Group for Clinical Cancer Research (SAKK) Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup.
Breast. 2014; 23(5):511-525
Web of Science PubMed FullText FullText_MUG

 

Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159
Web of Science PubMed FullText FullText_MUG

 

2013

Lechleitner, M; Pils, K; Roller-Wirnsberger, R; Beubler, E; Gasser, R; Mrak, P; Hoppichler, F; Pietschmann, P Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients].
Z GERONTOL GERIATRIE. 2013; 46(5): 390-397.
Web of Science PubMed FullText FullText_MUG

 

2012

Gnant, M; Balic, M; Petru, E; Raunik, W; Singer, CF; Steger, GG; Watzke, IM; Brodowicz, T Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
Breast Care (Basel). 2012; 7(2):92-98 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Muschitz, C; Fahrleitner-Pammer, A; Huber, J; Preisinger, E; Kudlacek, S; Resch, H Update on denosumab in postmenopausal osteoporosis--recent clinical data.
Wien Med Wochenschr. 2012; 162(17-18):374-379
PubMed FullText FullText_MUG

 

2010

Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR) Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Wien Med Wochenschr. 2010; 160(21-22):586-589
PubMed FullText FullText_MUG

 

Reid, I; Miller, P; Brown, J; Kendler, D; Fahrleitner-Pammer, A; Valter, I; Maasalu, K; Bolognese, M; Woodson, G; Bone, H; Ding, B; Wagman, R; Martin, JS; Ominsky, M; Dempster, D; on behalf of the Denosumab Phase 3 Bone Histology Study Group Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.
J Bone Miner Res. 2010; 25(10): 2256-2265. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Cummings, SR; San Martin, J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM Trial Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
N Engl J Med. 2009; 361(8): 756-765. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum